LXRX
Lexicon Pharmaceuticals, Inc.Company with tickers: LXRX
CIK
1062822
CUSIP
528872302
Shares Outstanding
444,196,390
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-01 | Amouyal Philippe | Director | Award | 35,714 |
| 2026-05-01 | Amouyal Philippe | Director | Award | 43,478 |
| 2026-05-01 | SOBECKI CHRISTOPHER J | Director | Award | 35,714 |
| 2026-05-01 | SOBECKI CHRISTOPHER J | Director | Award | 43,478 |
| 2026-05-01 | BARKER SAM L | Director | Award | 43,478 |
| 2026-05-01 | BARKER SAM L | Director | Award | 35,714 |
| 2026-05-01 | Swain Judith L | Director | Award | 35,714 |
| 2026-05-01 | Swain Judith L | Director | Award | 43,478 |
| 2026-05-01 | Sullivan Diane E. | Director | Award | 35,714 |
| 2026-05-01 | Sullivan Diane E. | Director | Award | 43,478 |
| 2026-05-01 | DEBBANE RAYMOND | Director | Award | 35,714 |
| 2026-05-01 | DEBBANE RAYMOND | Director | Award | 43,478 |
| 2026-05-01 | Cheung Ivan | Director | Award | 43,478 |
| 2026-05-01 | Cheung Ivan | Director | Award | 35,714 |
| 2026-04-30 | Artal Participations S.a r.l. | Director, 10% Owner | Convert | 408,434 |
| 2026-04-30 | Artal Participations S.a r.l. | Director, 10% Owner | Convert | 20,421,735 |
| 2026-04-30 | Artal Participations S.a r.l. | Director, 10% Owner | Award | 408,434 |
| 2026-02-28 | Crum Brian T | SVP, General Counsel & Secr. | Convert | 69,386 |
| 2026-02-28 | Crum Brian T | SVP, General Counsel & Secr. | Convert | 170,163 |
| 2026-02-28 | Crum Brian T | SVP, General Counsel & Secr. | Convert | 33,457 |
| 2026-02-28 | Crum Brian T | SVP, General Counsel & Secr. | Convert | 170,163 |
| 2026-02-28 | Crum Brian T | SVP, General Counsel & Secr. | Convert | 33,457 |
| 2026-02-28 | Crum Brian T | SVP, General Counsel & Secr. | Tax | 105,019 |
| 2026-02-28 | Crum Brian T | SVP, General Counsel & Secr. | Convert | 69,386 |
| 2026-02-28 | McDermott Wendy | SVP, Human Resources | Convert | 144,393 |
| 2026-02-28 | McDermott Wendy | SVP, Human Resources | Convert | 52,316 |
| 2026-02-28 | McDermott Wendy | SVP, Human Resources | Convert | 52,316 |
| 2026-02-28 | McDermott Wendy | SVP, Human Resources | Convert | 27,697 |
| 2026-02-28 | McDermott Wendy | SVP, Human Resources | Convert | 27,697 |
| 2026-02-28 | McDermott Wendy | SVP, Human Resources | Tax | 68,107 |
| 2026-02-28 | McDermott Wendy | SVP, Human Resources | Convert | 144,393 |
| 2026-02-28 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | Tax | 35,826 |
| 2026-02-28 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | Convert | 67,090 |
| 2026-02-28 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | Convert | 67,090 |
| 2026-02-28 | Granowitz Craig B | SVP, Chief Medical Officer | Tax | 109,098 |
| 2026-02-28 | Granowitz Craig B | SVP, Chief Medical Officer | Convert | 202,260 |
| 2026-02-28 | Granowitz Craig B | SVP, Chief Medical Officer | Convert | 202,260 |
| 2026-02-28 | Granowitz Craig B | SVP, Chief Medical Officer | Convert | 35,790 |
| 2026-02-28 | Granowitz Craig B | SVP, Chief Medical Officer | Convert | 35,790 |
| 2026-02-28 | Granowitz Craig B | SVP, Chief Medical Officer | Convert | 74,226 |
| 2026-02-28 | Granowitz Craig B | SVP, Chief Medical Officer | Convert | 74,226 |
| 2026-02-28 | Gopinathan Suma | SVP, Discovery | Convert | 14,000 |
| 2026-02-28 | Gopinathan Suma | SVP, Discovery | Convert | 65,640 |
| 2026-02-28 | Gopinathan Suma | SVP, Discovery | Convert | 65,640 |
| 2026-02-28 | Gopinathan Suma | SVP, Discovery | Convert | 20,310 |
| 2026-02-28 | Gopinathan Suma | SVP, Discovery | Convert | 14,000 |
| 2026-02-28 | Gopinathan Suma | SVP, Discovery | Convert | 20,310 |
| 2026-02-28 | Gopinathan Suma | SVP, Discovery | Tax | 24,338 |
| 2026-02-28 | Exton Michael | Director, Chief Executive Officer | Convert | 503,263 |
| 2026-02-28 | Exton Michael | Director, Chief Executive Officer | Convert | 503,263 |
| 2026-02-28 | DeFrancesco Lisa | SVP, IR and Corp Comm | Convert | 128,190 |
| 2026-02-28 | DeFrancesco Lisa | SVP, IR and Corp Comm | Tax | 74,572 |
| 2026-02-28 | DeFrancesco Lisa | SVP, IR and Corp Comm | Convert | 24,674 |
| 2026-02-28 | DeFrancesco Lisa | SVP, IR and Corp Comm | Convert | 24,674 |
| 2026-02-28 | DeFrancesco Lisa | SVP, IR and Corp Comm | Convert | 128,190 |
| 2026-02-28 | Coiante Scott M | SVP, Chief Financial Officer | Convert | 160,237 |
| 2026-02-28 | Coiante Scott M | SVP, Chief Financial Officer | Convert | 160,237 |
| 2026-02-28 | Coiante Scott M | SVP, Chief Financial Officer | Tax | 54,881 |
| 2026-02-28 | Exton Michael | Director, Chief Executive Officer | Tax | 204,831 |
| 2026-02-25 | DEBBANE RAYMOND | Director | Buy | 2,000 |
| 2026-02-25 | DEBBANE RAYMOND | Director | Other | 5,451,204 |
| 2026-02-25 | DEBBANE RAYMOND | Director | Other | 1,538,462 |
| 2026-02-25 | DEBBANE RAYMOND | Director | Other | 35,402,689 |
| 2026-02-25 | DEBBANE RAYMOND | Director | Other | 7,362,368 |
| 2026-02-23 | DEBBANE RAYMOND | Director | Other | 5,451,204 |
| 2026-02-23 | DEBBANE RAYMOND | Director | Buy | 100,000 |
| 2026-02-23 | DEBBANE RAYMOND | Director | Other | 7,362,368 |
| 2026-02-23 | DEBBANE RAYMOND | Director | Other | 1,538,462 |
| 2026-02-23 | DEBBANE RAYMOND | Director | Other | 35,402,689 |
| 2026-02-20 | DEBBANE RAYMOND | Director | Buy | 100,000 |
| 2026-02-19 | DEBBANE RAYMOND | Director | Other | 1,538,462 |
| 2026-02-19 | DEBBANE RAYMOND | Director | Other | 7,362,368 |
| 2026-02-19 | DEBBANE RAYMOND | Director | Other | 35,402,689 |
| 2026-02-19 | DEBBANE RAYMOND | Director | Buy | 50,000 |
| 2026-02-19 | DEBBANE RAYMOND | Director | Other | 5,451,204 |
| 2026-02-18 | DEBBANE RAYMOND | Director | Buy | 133,688 |
| 2026-02-17 | DEBBANE RAYMOND | Director | Buy | 76,857 |
| 2026-02-17 | Artal Participations S.a r.l. | Director, 10% Owner | Award | 41,289 |
| 2026-02-13 | DEBBANE RAYMOND | Director | Other | 1,538,462 |
| 2026-02-13 | DEBBANE RAYMOND | Director | Other | 7,362,368 |
| 2026-02-13 | DEBBANE RAYMOND | Director | Other | 35,402,689 |
| 2026-02-13 | DEBBANE RAYMOND | Director | Buy | 57,952 |
| 2026-02-13 | DEBBANE RAYMOND | Director | Other | 5,451,204 |
| 2026-02-12 | Gopinathan Suma | SVP, Discovery | Award | 357,680 |
| 2026-02-12 | Gopinathan Suma | SVP, Discovery | Award | 238,450 |
| 2026-02-12 | DeFrancesco Lisa | SVP, IR and Corp Comm | Award | 386,300 |
| 2026-02-12 | DeFrancesco Lisa | SVP, IR and Corp Comm | Award | 257,530 |
| 2026-02-12 | Crum Brian T | SVP, General Counsel & Secr. | Award | 299,710 |
| 2026-02-12 | Crum Brian T | SVP, General Counsel & Secr. | Award | 449,560 |
| 2026-02-12 | Coiante Scott M | SVP, Chief Financial Officer | Award | 272,680 |
| 2026-02-12 | Coiante Scott M | SVP, Chief Financial Officer | Award | 409,020 |
| 2026-02-12 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | Award | 290,620 |
| 2026-02-12 | Martens Rachel Yap | SVP, Partnerships & Corp Strat | Award | 193,740 |
| 2026-02-12 | McDermott Wendy | SVP, Human Resources | Award | 375,300 |
| 2026-02-12 | McDermott Wendy | SVP, Human Resources | Award | 250,200 |
| 2026-02-12 | Granowitz Craig B | SVP, Chief Medical Officer | Award | 519,920 |
| 2026-02-12 | Granowitz Craig B | SVP, Chief Medical Officer | Award | 346,610 |
| 2026-02-12 | Exton Michael | Director, Chief Executive Officer | Award | 1,293,670 |
| 2026-02-12 | Exton Michael | Director, Chief Executive Officer | Award | 862,440 |
| 2026-02-02 | Invus Global Management, LLC | Director, 10% Owner | Other | 5,451,204 |